chr2-96145066-A-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004418.4(DUSP2):​c.289T>G​(p.Ser97Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

DUSP2
NM_004418.4 missense

Scores

1
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.97

Publications

0 publications found
Variant links:
Genes affected
DUSP2 (HGNC:3068): (dual specificity phosphatase 2) The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK1 and ERK2, is predominantly expressed in hematopoietic tissues, and is localized in the nucleus. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24736726).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004418.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DUSP2
NM_004418.4
MANE Select
c.289T>Gp.Ser97Ala
missense
Exon 1 of 4NP_004409.1Q05923

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DUSP2
ENST00000288943.5
TSL:1 MANE Select
c.289T>Gp.Ser97Ala
missense
Exon 1 of 4ENSP00000288943.4Q05923
DUSP2
ENST00000718436.1
c.289T>Gp.Ser97Ala
missense
Exon 1 of 4ENSP00000520821.1Q05923
DUSP2
ENST00000914868.1
c.289T>Gp.Ser97Ala
missense
Exon 1 of 4ENSP00000584927.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
19
DANN
Benign
0.82
DEOGEN2
Benign
0.15
T
Eigen
Benign
0.12
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.29
T
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.25
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
2.0
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.060
Sift
Benign
0.81
T
Sift4G
Benign
0.74
T
Polyphen
0.89
P
Vest4
0.079
MutPred
0.37
Loss of phosphorylation at S97 (P = 0.0268)
MVP
0.70
MPC
1.0
ClinPred
0.31
T
GERP RS
4.1
PromoterAI
0.025
Neutral
Varity_R
0.11
gMVP
0.30
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1488786293; hg19: chr2-96810805; API